Title |
A 4-Year Follow-Up Study of Attention-Deficit Hyperactivity Symptoms, Comorbidities, and Psychostimulant Use in a Brazilian Sample of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
|
---|---|
Published in |
Frontiers in Psychiatry, October 2015
|
DOI | 10.3389/fpsyt.2015.00135 |
Pubmed ID | |
Authors |
Sonia M. M. Palma, Ana Carolina M. P. Natale, Helena M. Calil |
Abstract |
The aim of this study was to evaluate symptom persistence in attention-deficit/hyperactivity disorder (ADHD), the development of comorbidities, and psychostimulant usage patterns. Follow-up studies were conducted in 37 patients with ADHD and 22 healthy controls, aged 10 and 18, 4 years after their first assessment. The ADHD was rated as persistent if participants met all DSM-IV criteria for syndromic or sub-threshold persistence, or had functional impairments (functional persistence). Of the 37 ADHD patients we reevaluated, 75% had persistent symptoms, and psychiatric comorbidities with additional functional impairments and academic problems were more common than in controls. These follow-up findings show a high comorbidity associated with ADHD and support the importance of evaluation and treatment for ADHD and comorbidities throughout life. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 3% |
Unknown | 35 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 7 | 19% |
Researcher | 3 | 8% |
Student > Ph. D. Student | 3 | 8% |
Lecturer | 3 | 8% |
Student > Doctoral Student | 2 | 6% |
Other | 9 | 25% |
Unknown | 9 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 10 | 28% |
Medicine and Dentistry | 5 | 14% |
Neuroscience | 5 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Economics, Econometrics and Finance | 1 | 3% |
Other | 3 | 8% |
Unknown | 11 | 31% |